Azacitidine

Azacitidine for injection is a nucleoside metabolic inhibitor indicated for the treatment of patients with the following FAB myelodysplastic syndrome (MDS) subtypes: Refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).

For indications, dosing and other information, please refer to the prescribing information.

Azacitidine ‐ Breckenridge

Size:
100 mg vial
NDC #:
51991-0797-98
Download:
PI

Azacitidine ‐ Mylan

Size:
100 mg vial
NDC #:
67457-0254-30
Download:
PI

Azacitidine ‐ Dr. Reddy's

Size:
100 mg vial
NDC #:
43598-0305-62
Download:
PI